Home › Funds › SUPERSTRING CAPITAL MANAGEMENT LP › CLDX

SUPERSTRING CAPITAL MANAGEMENT LP position in CLDX

CELLDEX THERAPEUTICS INC NEW · Health Care

SUPERSTRING CAPITAL MANAGEMENT LP reported holding 287,583 shares of CLDX (CELLDEX THERAPEUTICS INC NEW) in its Q2 2026 13F filing — a position valued at US$10.7M, representing 6.76% of its reported portfolio and ranking #4 among its reported holdings. SUPERSTRING CAPITAL MANAGEMENT LP has disclosed CLDX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)287.58K sh
Reported value held$10.70M
Portfolio Weight6.76%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SUPERSTRING CAPITAL MANAGEMENT LP's CLDX position evolved

SUPERSTRING CAPITAL MANAGEMENT LP first disclosed a stake in CLDX in Q4 2025 at 88,308 shares (US$2.4M). The position peaked in Q2 2026 at 287,583 shares, worth US$10.7M. Across 3 filings, SUPERSTRING CAPITAL MANAGEMENT LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 287,583 shares valued at US$10.7M — an increase of 107,535 shares quarter over quarter.. Notable position changes include a 104% increase in Q1 2026 (shares rose 17% over the following quarter), a 60% increase in Q2 2026 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 88.31K $2.40M New
Q1 2026 180.05K $5.71M Add
Q2 2026 287.58K $10.70M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CLDX and 13F data

CLDX (CELLDEX THERAPEUTICS INC NEW) is a Health Care company. 44 other funds we track also report a position in CLDX — the largest reported positions include Kynam Capital Management, LP (US$198.1M), Deep Track Capital, LP (US$109.4M), Logos Global Management LP (US$78.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CLDX

All CLDX fund holders →

FAQ

How long has SUPERSTRING CAPITAL MANAGEMENT LP held CLDX?

SUPERSTRING CAPITAL MANAGEMENT LP has disclosed CLDX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in CLDX?

As of Q2 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 287.58K shares of CLDX (CELLDEX THERAPEUTICS INC NEW), valued at $10.70M, representing 6.76% of its reported portfolio and ranking #4.

Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling CLDX?

In the latest 13F filing (Q2 2026), SUPERSTRING CAPITAL MANAGEMENT LP increased its position in CLDX. The position peaked in Q2 2026 at 287.58K shares.

Which other funds hold CLDX?

Other major institutional holders of CLDX include Kynam Capital Management, LP, Deep Track Capital, LP, Logos Global Management LP, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.